Financhill
Back

Cleveland-Cliffs Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
31

CLF
Cleveland-Cliffs

Last Price:
$6.93
Seasonality Move:
2.18%
Sell
37

REGN
Regeneron Pharmaceuticals

Last Price:
$511.36
Seasonality Move:
9.62%
Sell
31
Cleveland-Cliffs (CLF) is a Sell

Is Cleveland-Cliffs a Buy, Sell or Hold?

  • The current Cleveland-Cliffs [CLF] share price is $6.92. The Score for CLF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $511.92. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLF Stock Price Chart

What is Cleveland-Cliffs's stock price today?

  • The Cleveland-Cliffs share price today is $6.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLF is experiencing slight buying pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $511.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

CLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 44.89 Sell
Chaikin Money Flow: 13895501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.52 - 7.68) Sell
Bollinger Bands (100): (7.06 - 10.22) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -15.8 Sell
Relative Strength Index (14 RSI): 41.99 Sell
Chaikin Money Flow: 6903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (493.73 - 586.57) Sell
Bollinger Bands (100): (544.54 - 680.88) Sell

CLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.24 Sell
20-day SMA: 7.06 Sell
50-day SMA: 7.42 Sell
200-day SMA: 10.15 Sell
8-day EMA: 7.21 Sell
20-day EMA: 7.25 Sell
50-day EMA: 7.6 Sell
200-day EMA: 10.12 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 517.06 Sell
20-day SMA: 524.83 Sell
50-day SMA: 557.23 Sell
200-day SMA: 746.46 Sell
8-day EMA: 514.66 Sell
20-day EMA: 526.87 Sell
50-day EMA: 559.44 Sell
200-day EMA: 704.1 Sell

Cleveland-Cliffs Earnings Growth & CLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.44 per share, a decrease this year of $1.29 per share, and an increase next year of $2.45 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.72 per share.

Cleveland-Cliffs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):